Larson Financial Group »

Rapport Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5k 83 30.34

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Global Equity SHS (CGGE)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Applied Materials (AMAT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pgim Etf Tr Active Aggregate (PAB)

View all positions for Larson Financial Group

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics